0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-9I18251
Home | Market Reports | Science
Global Polystyrene Latex Particle for In Vitro Diagnostics Market Research Report 2024
BUY CHAPTERS

Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Research Report 2026

Code: QYRE-Auto-9I18251
Report
2026-02-26
Pages:114
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Polystyrene Latex Particle for In-Vitro Diagnostics Market Size

The global Polystyrene Latex Particle for In-Vitro Diagnostics market was valued at US$ 53.13 million in 2025 and is anticipated to reach US$ 76.88 million by 2032, at a CAGR of 5.5% from 2026 to 2032.

Polystyrene Latex Particle for In-Vitro Diagnostics Market

Polystyrene Latex Particle for In-Vitro Diagnostics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Polystyrene Latex Particle for In-Vitro Diagnostics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Latex particles, also known as latex microspheres, are small, spherical beads made from polystyrene that are typically used in a variety of in-vitro diagnostic (IVD) applications. These particles are widely employed due to their high surface area, uniform size, ease of functionalization, and ability to carry various reagents or biomolecules (e.g., antibodies, antigens, nucleic acids) for detecting specific analytes in biological samples.
Market Size and Growth:
The global in-vitro diagnostics (IVD) market, including polystyrene latex particles, is expected to grow steadily, driven by an increasing demand for point-of-care testing, disease diagnostics, and home care kits.
Technological Developments:
Advances in automation for both polystyrene latex particle production and the diagnostic processes (such as in high-throughput screening) are driving the adoption of latex-based tests, particularly in clinical labs and high-volume testing environments.
Competitive Landscape:
The market for polystyrene latex particles in diagnostics is highly competitive, with several large multinational companies dominating the market. However, there is also significant competition from specialized companies offering more tailored and niche solutions.
Aging Population:
The aging global population is leading to an increase in age-related diseases such as Alzheimer’s, diabetes, and cancer. As the elderly population grows, the demand for effective diagnostic solutions, including those based on polystyrene latex particles, will continue to rise.
This report delivers a comprehensive overview of the global Polystyrene Latex Particle for In-Vitro Diagnostics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Polystyrene Latex Particle for In-Vitro Diagnostics. The Polystyrene Latex Particle for In-Vitro Diagnostics market size, estimates, and forecasts are provided in terms of sales volume (Liters) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Polystyrene Latex Particle for In-Vitro Diagnostics market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Polystyrene Latex Particle for In-Vitro Diagnostics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Polystyrene Latex Particle for In-Vitro Diagnostics Market Report

Report Metric Details
Report Name Polystyrene Latex Particle for In-Vitro Diagnostics Market
Accounted market size in 2025 US$ 53.13 million
Forecasted market size in 2032 US$ 76.88 million
CAGR 5.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Plain Latex Particles
  • Modified Latex Particles
by Application
  • Latex Immunoturbidimetry
  • Latex Agglutination Test
  • Immunochromatography
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company JSR Life Sciences, Merck, VDO Biotech, Bangs Laboratories, Thermo Fisher, Agilent, Fujikura Kasei, Suzhou NanoMicro, IKERLAT Polymers, Sunresin New Materials
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Polystyrene Latex Particle for In-Vitro Diagnostics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Polystyrene Latex Particle for In-Vitro Diagnostics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Polystyrene Latex Particle for In-Vitro Diagnostics Market growing?

Ans: The Polystyrene Latex Particle for In-Vitro Diagnostics Market witnessing a CAGR of 5.5% during the forecast period 2026-2032.

What is the Polystyrene Latex Particle for In-Vitro Diagnostics Market size in 2032?

Ans: The Polystyrene Latex Particle for In-Vitro Diagnostics Market size in 2032 will be US$ 76.88 million.

Who are the main players in the Polystyrene Latex Particle for In-Vitro Diagnostics Market report?

Ans: The main players in the Polystyrene Latex Particle for In-Vitro Diagnostics Market are JSR Life Sciences, Merck, VDO Biotech, Bangs Laboratories, Thermo Fisher, Agilent, Fujikura Kasei, Suzhou NanoMicro, IKERLAT Polymers, Sunresin New Materials

What are the Application segmentation covered in the Polystyrene Latex Particle for In-Vitro Diagnostics Market report?

Ans: The Applications covered in the Polystyrene Latex Particle for In-Vitro Diagnostics Market report are Latex Immunoturbidimetry, Latex Agglutination Test, Immunochromatography, Other

What are the Type segmentation covered in the Polystyrene Latex Particle for In-Vitro Diagnostics Market report?

Ans: The Types covered in the Polystyrene Latex Particle for In-Vitro Diagnostics Market report are Plain Latex Particles, Modified Latex Particles

1 Polystyrene Latex Particle for In-Vitro Diagnostics Market Overview
1.1 Product Definition
1.2 Polystyrene Latex Particle for In-Vitro Diagnostics by Type
1.2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Value by Type: 2025 vs 2032
1.2.2 Plain Latex Particles
1.2.3 Modified Latex Particles
1.3 Polystyrene Latex Particle for In-Vitro Diagnostics by Application
1.3.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Value by Application: 2025 vs 2032
1.3.2 Latex Immunoturbidimetry
1.3.3 Latex Agglutination Test
1.3.4 Immunochromatography
1.3.5 Other
1.4 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Size Estimates and Forecasts
1.4.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue 2021–2032
1.4.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales 2021–2032
1.4.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Polystyrene Latex Particle for In-Vitro Diagnostics Market Competition by Manufacturers
2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Polystyrene Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Polystyrene Latex Particle for In-Vitro Diagnostics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Polystyrene Latex Particle for In-Vitro Diagnostics, Product Types and Applications
2.7 Global Key Manufacturers of Polystyrene Latex Particle for In-Vitro Diagnostics, Date of Entry into the Industry
2.8 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Competitive Situation and Trends
2.8.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Polystyrene Latex Particle for In-Vitro Diagnostics Players Market Share by Revenue
2.8.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Scenario by Region
3.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Region: 2021–2032
3.2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Region: 2021–2026
3.2.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Region: 2027–2032
3.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Region: 2021–2032
3.3.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Region: 2021–2026
3.3.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Region: 2027–2032
3.4 North America Polystyrene Latex Particle for In-Vitro Diagnostics Market Facts & Figures by Country
3.4.1 North America Polystyrene Latex Particle for In-Vitro Diagnostics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (2021–2032)
3.4.3 North America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Polystyrene Latex Particle for In-Vitro Diagnostics Market Facts & Figures by Country
3.5.1 Europe Polystyrene Latex Particle for In-Vitro Diagnostics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (2021–2032)
3.5.3 Europe Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Market Facts & Figures by Region
3.6.1 Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Region (2021–2032)
3.6.3 Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Market Facts & Figures by Country
3.7.1 Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (2021–2032)
3.7.3 Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Market Facts & Figures by Country
3.8.1 Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Type (2021–2032)
4.1.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Type (2021–2026)
4.1.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Type (2027–2032)
4.1.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2021–2032)
4.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Type (2021–2032)
4.2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Type (2021–2026)
4.2.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Type (2027–2032)
4.2.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2021–2032)
4.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Application (2021–2032)
5.1.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Application (2021–2026)
5.1.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Application (2027–2032)
5.1.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2021–2032)
5.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Application (2021–2032)
5.2.1 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Application (2021–2026)
5.2.2 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Application (2027–2032)
5.2.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2021–2032)
5.3 Global Polystyrene Latex Particle for In-Vitro Diagnostics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 JSR Life Sciences
6.1.1 JSR Life Sciences Company Information
6.1.2 JSR Life Sciences Description and Business Overview
6.1.3 JSR Life Sciences Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 JSR Life Sciences Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.1.5 JSR Life Sciences Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 VDO Biotech
6.3.1 VDO Biotech Company Information
6.3.2 VDO Biotech Description and Business Overview
6.3.3 VDO Biotech Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 VDO Biotech Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.3.5 VDO Biotech Recent Developments/Updates
6.4 Bangs Laboratories
6.4.1 Bangs Laboratories Company Information
6.4.2 Bangs Laboratories Description and Business Overview
6.4.3 Bangs Laboratories Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bangs Laboratories Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.4.5 Bangs Laboratories Recent Developments/Updates
6.5 Thermo Fisher
6.5.1 Thermo Fisher Company Information
6.5.2 Thermo Fisher Description and Business Overview
6.5.3 Thermo Fisher Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Thermo Fisher Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.5.5 Thermo Fisher Recent Developments/Updates
6.6 Agilent
6.6.1 Agilent Company Information
6.6.2 Agilent Description and Business Overview
6.6.3 Agilent Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Agilent Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.6.5 Agilent Recent Developments/Updates
6.7 Fujikura Kasei
6.7.1 Fujikura Kasei Company Information
6.7.2 Fujikura Kasei Description and Business Overview
6.7.3 Fujikura Kasei Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Fujikura Kasei Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.7.5 Fujikura Kasei Recent Developments/Updates
6.8 Suzhou NanoMicro
6.8.1 Suzhou NanoMicro Company Information
6.8.2 Suzhou NanoMicro Description and Business Overview
6.8.3 Suzhou NanoMicro Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Suzhou NanoMicro Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.8.5 Suzhou NanoMicro Recent Developments/Updates
6.9 IKERLAT Polymers
6.9.1 IKERLAT Polymers Company Information
6.9.2 IKERLAT Polymers Description and Business Overview
6.9.3 IKERLAT Polymers Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 IKERLAT Polymers Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.9.5 IKERLAT Polymers Recent Developments/Updates
6.10 Sunresin New Materials
6.10.1 Sunresin New Materials Company Information
6.10.2 Sunresin New Materials Description and Business Overview
6.10.3 Sunresin New Materials Polystyrene Latex Particle for In-Vitro Diagnostics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Sunresin New Materials Polystyrene Latex Particle for In-Vitro Diagnostics Product Portfolio
6.10.5 Sunresin New Materials Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polystyrene Latex Particle for In-Vitro Diagnostics Industry Chain Analysis
7.2 Polystyrene Latex Particle for In-Vitro Diagnostics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polystyrene Latex Particle for In-Vitro Diagnostics Production Mode & Process Analysis
7.4 Polystyrene Latex Particle for In-Vitro Diagnostics Sales and Marketing
7.4.1 Polystyrene Latex Particle for In-Vitro Diagnostics Sales Channels
7.4.2 Polystyrene Latex Particle for In-Vitro Diagnostics Distributors
7.5 Polystyrene Latex Particle for In-Vitro Diagnostics Customer Analysis
8 Polystyrene Latex Particle for In-Vitro Diagnostics Market Dynamics
8.1 Polystyrene Latex Particle for In-Vitro Diagnostics Industry Trends
8.2 Polystyrene Latex Particle for In-Vitro Diagnostics Market Drivers
8.3 Polystyrene Latex Particle for In-Vitro Diagnostics Market Challenges
8.4 Polystyrene Latex Particle for In-Vitro Diagnostics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters) of Key Manufacturers (2021–2026)
 Table 5. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Polystyrene Latex Particle for In-Vitro Diagnostics Average Price (US$/Liter) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Polystyrene Latex Particle for In-Vitro Diagnostics, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Polystyrene Latex Particle for In-Vitro Diagnostics, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Polystyrene Latex Particle for In-Vitro Diagnostics, Product Types and Applications
 Table 12. Global Key Manufacturers of Polystyrene Latex Particle for In-Vitro Diagnostics, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Polystyrene Latex Particle for In-Vitro Diagnostics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Polystyrene Latex Particle for In-Vitro Diagnostics Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Region (Liters), 2021–2026
 Table 18. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Region (2021–2026)
 Table 19. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Region (Liters), 2027–2032
 Table 20. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Region (2027–2032)
 Table 21. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2021–2026)
 Table 23. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2027–2032)
 Table 25. North America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (Liters), 2021–2026
 Table 27. North America Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (Liters), 2027–2032
 Table 28. North America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (Liters), 2021–2026
 Table 32. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (Liters), 2027–2032
 Table 33. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Region (Liters), 2021–2026
 Table 37. Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Region (Liters), 2027–2032
 Table 38. Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (Liters), 2021–2026
 Table 42. Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (Liters), 2027–2032
 Table 43. Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (Liters), 2021–2026
 Table 47. Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Sales by Country (Liters), 2027–2032
 Table 48. Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters) by Type (2021–2026)
 Table 51. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters) by Type (2027–2032)
 Table 52. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2021–2026)
 Table 53. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Type (2027–2032)
 Table 54. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2021–2026)
 Table 57. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Type (2027–2032)
 Table 58. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price (US$/Liter) by Type (2021–2026)
 Table 59. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price (US$/Liter) by Type (2027–2032)
 Table 60. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters) by Application (2021–2026)
 Table 61. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters) by Application (2027–2032)
 Table 62. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2021–2026)
 Table 63. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Application (2027–2032)
 Table 64. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2021–2026)
 Table 67. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Application (2027–2032)
 Table 68. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price (US$/Liter) by Application (2021–2026)
 Table 69. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price (US$/Liter) by Application (2027–2032)
 Table 70. JSR Life Sciences Company Information
 Table 71. JSR Life Sciences Description and Business Overview
 Table 72. JSR Life Sciences Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 73. JSR Life Sciences Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 74. JSR Life Sciences Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 78. Merck Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 79. Merck Recent Developments/Updates
 Table 80. VDO Biotech Company Information
 Table 81. VDO Biotech Description and Business Overview
 Table 82. VDO Biotech Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 83. VDO Biotech Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 84. VDO Biotech Recent Developments/Updates
 Table 85. Bangs Laboratories Company Information
 Table 86. Bangs Laboratories Description and Business Overview
 Table 87. Bangs Laboratories Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 88. Bangs Laboratories Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 89. Bangs Laboratories Recent Developments/Updates
 Table 90. Thermo Fisher Company Information
 Table 91. Thermo Fisher Description and Business Overview
 Table 92. Thermo Fisher Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 93. Thermo Fisher Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 94. Thermo Fisher Recent Developments/Updates
 Table 95. Agilent Company Information
 Table 96. Agilent Description and Business Overview
 Table 97. Agilent Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 98. Agilent Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 99. Agilent Recent Developments/Updates
 Table 100. Fujikura Kasei Company Information
 Table 101. Fujikura Kasei Description and Business Overview
 Table 102. Fujikura Kasei Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 103. Fujikura Kasei Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 104. Fujikura Kasei Recent Developments/Updates
 Table 105. Suzhou NanoMicro Company Information
 Table 106. Suzhou NanoMicro Description and Business Overview
 Table 107. Suzhou NanoMicro Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 108. Suzhou NanoMicro Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 109. Suzhou NanoMicro Recent Developments/Updates
 Table 110. IKERLAT Polymers Company Information
 Table 111. IKERLAT Polymers Description and Business Overview
 Table 112. IKERLAT Polymers Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 113. IKERLAT Polymers Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 114. IKERLAT Polymers Recent Developments/Updates
 Table 115. Sunresin New Materials Company Information
 Table 116. Sunresin New Materials Description and Business Overview
 Table 117. Sunresin New Materials Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), Revenue (US$ Million), Price (US$/Liter), and Gross Margin (2021–2026)
 Table 118. Sunresin New Materials Polystyrene Latex Particle for In-Vitro Diagnostics Product
 Table 119. Sunresin New Materials Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Polystyrene Latex Particle for In-Vitro Diagnostics Distributors List
 Table 123. Polystyrene Latex Particle for In-Vitro Diagnostics Customers List
 Table 124. Polystyrene Latex Particle for In-Vitro Diagnostics Market Trends
 Table 125. Polystyrene Latex Particle for In-Vitro Diagnostics Market Drivers
 Table 126. Polystyrene Latex Particle for In-Vitro Diagnostics Market Challenges
 Table 127. Polystyrene Latex Particle for In-Vitro Diagnostics Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Polystyrene Latex Particle for In-Vitro Diagnostics
 Figure 2. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Share by Type: 2025 & 2032
 Figure 4. Plain Latex Particles Product Picture
 Figure 5. Modified Latex Particles Product Picture
 Figure 6. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Share by Application: 2025 & 2032
 Figure 8. Latex Immunoturbidimetry
 Figure 9. Latex Agglutination Test
 Figure 10. Immunochromatography
 Figure 11. Other
 Figure 12. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Size (US$ Million), 2021–2032
 Figure 14. Global Polystyrene Latex Particle for In-Vitro Diagnostics Sales (Liters), 2021–2032
 Figure 15. Global Polystyrene Latex Particle for In-Vitro Diagnostics Average Price (US$/Liter), 2021–2032
 Figure 16. Polystyrene Latex Particle for In-Vitro Diagnostics Report Years Considered
 Figure 17. Polystyrene Latex Particle for In-Vitro Diagnostics Sales Share by Manufacturers in 2025
 Figure 18. Global Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Polystyrene Latex Particle for In-Vitro Diagnostics Players: Market Share by Revenue in Polystyrene Latex Particle for In-Vitro Diagnostics in 2025
 Figure 20. Polystyrene Latex Particle for In-Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Polystyrene Latex Particle for In-Vitro Diagnostics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Country (2021–2032)
 Figure 23. North America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Country (2021–2032)
 Figure 24. United States Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Country (2021–2032)
 Figure 27. Europe Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Region (2021–2032)
 Figure 35. China Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Polystyrene Latex Particle for In-Vitro Diagnostics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Polystyrene Latex Particle for In-Vitro Diagnostics by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Polystyrene Latex Particle for In-Vitro Diagnostics by Type (2021–2032)
 Figure 55. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price (US$/Liter) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Polystyrene Latex Particle for In-Vitro Diagnostics by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Polystyrene Latex Particle for In-Vitro Diagnostics by Application (2021–2032)
 Figure 58. Global Polystyrene Latex Particle for In-Vitro Diagnostics Price (US$/Liter) by Application (2021–2032)
 Figure 59. Polystyrene Latex Particle for In-Vitro Diagnostics Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String